Lymphoma in Castleman's disease, acute lymphocytic leukemia, adult T-cell leukemia and cutaneous T-cell lymphoma accompanied with high serum soluble Fas ligand levels.
Takubo
T
T
Department of Clinical and Laboratory Medicine, Osaka City University Medical School, Osaka, Japan.
Ohkura
H
H
Kumura
T
T
Ohta
K
K
Yamane
T
T
Hino
M
M
Kamitani
T
T
Tatsumi
N
N
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000743:Anemia, Hemolytic / Q000097:blood / Q000276:immunology; D000753:Anemia, Refractory / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood*; D005871:Castleman Disease / Q000097:blood*; D053222:Fas Ligand Protein; D005260:Female; D019337:Hematologic Neoplasms / Q000097:blood*; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000097:blood; D008228:Lymphoma, Non-Hodgkin / Q000097:blood*; D016410:Lymphoma, T-Cell, Cutaneous / Q000097:blood; D008297:Male; D008562:Membrane Glycoproteins / Q000097:blood*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood; D009196:Myeloproliferative Disorders / Q000097:blood; D009363:Neoplasm Proteins / Q000097:blood*; D011230:Precancerous Conditions / Q000097:blood*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood
D014408:Biomarkers, Tumor; C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins